Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 139.50
Bid: 138.00
Ask: 140.00
Change: 1.00 (0.72%)
Spread: 2.00 (1.449%)
Open: 140.00
High: 140.50
Low: 139.50
Prev. Close: 139.50
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Aug 2023 07:00

RNS Number : 0903I
Xaar PLC
03 August 2023
 

3 August 2023

 

Xaar plc

 

TRADING UPDATE

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2023.

 

TRADING

 

Continued strong trading - in line with expectations

 

· Revenue for the period anticipated to be £34.7 million (H1 2022: £36.6 million).

· Adjusted profit before tax in line with management expectations, with the impact of the successful factory re-organisation offset by the planned sale of £1.8 million of non-core IP assets.

 

Further strategic and operational progress

 

· Increasing number of customers developing products using Aquinox with product launches expected in H2 2023.

· Commercial partnership with Quantica announced on 5 July 2023 enhances the Group's position in leading the market in printing highly viscous fluids.

· Phase one of factory efficiency programme completed on time and within budget.

· Product Print Systems business ("EPS") delivered a strong performance in the period with both revenue and margin growth.

 

 

BALANCE SHEET

 

The Group remains well capitalised with a strong balance sheet and with a net cash position as at 30 June 2023 of £7.3 million (30 June 2022: £12.6 million) in line with management expectations, reflecting the previously communicated investment in inventory predominantly in H2 2022.

 

 

OUTLOOK

 

· Market conditions expected to improve further in China in H2 and coupled with increased customer product launches will increase demand for Xaar printheads.

· Our strategy to diversify across a range of market sectors means further product launches are expected in 2024 providing confidence in delivering our mid-term growth plans.

· Previous investment in inventory holding means the Group is well placed to capitalise on further commercial opportunities.

· While remaining vigilant to broader macroeconomic conditions the Board continues to expect to deliver its expectations for the full year.

 

 

John Mills, Chief Executive Officer, commented:

 

"We remain focused on the delivery of our strategy and taking advantage of the significant opportunities we have that will drive profitable growth. Our products continue to generate strong interest from customers, demonstrating our leadership in printing highly viscous fluids with all the sustainability benefits they can deliver. We have positive momentum, a growing product pipeline and look forward to continuing to accelerate our strategy and performance in H2 and into 2024."

 

 

 

Note: Adjusted profit before tax is profit before tax excluding the impact of share-based payment charges, exchange differences relating to intra-group transactions, gain on derivative financial instruments, restructuring and transaction expenses, research and development expenditure credit, fair value gain on financial assets at fair value through profit and loss, and amortisation of acquired intangible assets.

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Teneo

+44 (0) 207 353 4200

Giles Kernick

Olivia Lucas

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKBBBDBKDPFK
Date   Source Headline
17th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSHolding(s) in Company
4th Mar 20107:00 amRNSDirectorate Change
1st Mar 20107:00 amRNSNotice of Final Results
19th Feb 20109:00 amRNSHolding(s) in Company
21st Jan 20107:00 amRNSPeriod end trading update
26th Oct 200910:42 amRNSHolding(s) in Company
14th Oct 20097:00 amRNSInterim Management Statement
16th Sep 20093:19 pmRNSHolding(s) in Company
10th Sep 200911:18 amRNSHolding(s) in Company
2nd Sep 20099:59 amRNSHolding(s) in Company
19th Aug 20097:00 amRNSHalf Yearly Report & Results
11th Aug 20097:00 amRNSNotice of Half Yearly Report
15th Jul 20097:00 amRNSHalf year period-end trading update
5th Jun 20091:22 pmRNSHolding(s) in Company
2nd Jun 200911:26 amRNSHolding(s) in Company
2nd Jun 200911:24 amRNSHolding(s) in Company
5th May 20095:04 pmRNSHolding(s) in Company
29th Apr 20092:06 pmRNSResult of AGM
16th Apr 20093:23 pmRNSGrant of Options
16th Apr 20097:00 amRNSAnnual Information Update
16th Apr 20097:00 amRNSInterim Management Statement
8th Apr 20099:35 amRNSChange of Adviser
7th Apr 20094:47 pmRNSDirector/PDMR Shareholding
3rd Apr 20093:38 pmRNSDirector/PDMR Shareholding
1st Apr 20094:04 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSManufacturing rationalisation
26th Mar 20095:21 pmRNSDirector/PDMR Shareholding
25th Mar 200910:38 amRNSDirector/PDMR Shareholding
23rd Mar 20097:00 amRNSFinal Results
13th Mar 20094:40 pmRNSSecond Price Monitoring Extn
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.